Evidence map›Paper›PMID 38456095›Full record

ArticleThe Lancet regional health. Western Pacific2024

Trends in major non-communicable diseases and related risk factors in China 2002-2019: an analysis of nationally representative survey data.

Wen Peng, Shiqi Chen, Xinguang Chen, Yue Ma, Tingting Wang, Xiaomin Sun, Yaogang Wang, Gangqiang Ding, Youfa Wang

Open access · goldAbstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
32.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Guangdong Biobank Cohort (GDBC) study.European journal of epidemiology · 2026
    Article
  18. Article
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Wen PengNutrition and Health Promotion Center, Department of Public Health, Medical College, Qinghai University; Qinghai Provincial Key Laboratory of Prevention and Control of Glucolipid Metabolic Diseases with Traditional Chinese Medicine, Xining, Qinghai, China.
Shiqi ChenInternational Obesity and Metabolic Disease Research Center, Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Xinguang ChenInternational Obesity and Metabolic Disease Research Center, Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Yue MaInternational Obesity and Metabolic Disease Research Center, Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Tingting WangInternational Obesity and Metabolic Disease Research Center, Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Xiaomin SunInternational Obesity and Metabolic Disease Research Center, Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Yaogang WangSchool of Public Health, Tianjin Medical University; School of Integrative Medicine, Public Health Science and Engineering College, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Gangqiang DingNational Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China.
Youfa WangInternational Obesity and Metabolic Disease Research Center, Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Xi'an Jiaotong University · CNTianjin University of Traditional Chinese Medicine · CNChinese Center For Disease Control and Prevention · CNQinghai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prevention and control of non-communicable diseases (NCDs) are prioritized in both the Sustainable Development Goal and the Healthy China 2030 Initiatives. Efforts have been devoted to combating NCDs in China. This study examined changes in NCD trajectory. Methods: We described and analyzed the trends in prevalence and control of major NCDs including obesity, hypertension, diabetes, and dyslipidemia and examined selected main behavioral risk factors in China by sex, age group, and residence using nationally representative CDC survey data. Data included were from the China Chronic Disease Risk Factor Surveillance (CCDRFS, 2013 and 2018) and China National Nutrition Survey (CNNS, 2002, 2010-2013, 2015, and 2020). Annual and relative changes in rates were used. Rural-urban ratio of related indicators was assessed. Findings: NCD-attributed deaths increased from 80.0% in 2002 to 86.6% in 2012, and 88.5% in 2019, with cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes accounted for 47.1%, 24.1%, 8.8%, and 2.5% of deaths in 2019, respectively. Prevalence of obesity (7.1%-16.4%), overweight/obesity (29.9%-50.7%), hypertension (18.8%-27.5%), diabetes (2.6%-11.9%), and dyslipidemia (18.6%-35.6%) all increased from 2002 to 2018. These rates increased faster in rural areas than in urban areas. Rates of awareness, treatment and control of hypertension and diabetes increased very slowly from 2012 to 2018. Most rates were between 30 and 40% with the lowest rate of 11% for hypertension control even in 2018. The rates were worse for rural residents compared to urban residents. Furthermore, many modifiable behavioral risk factors showed little improvement and some became worse over time, including smoking, excessive alcohol use, inadequate vegetable/fruit intake, excessive red meat intake, and physical inactivity. Interpretation: NCD burden in China increased during 2002-2019 despite of the intervention efforts. To reach the global and national targets, China must strengthen its actions, especially in rural areas, including improvement of NCD screening and management and reduction of behavioral risk factors. Funding: The study was supported in part by research grants of National Key R&D Program of China (2017YFC0907200, 2017YFC0907201), International Collaboration Project from the Chinese Ministry of Science and Technology-Prevention and control of chronic diseases and health promotion (G2021170007L), Natural Scientific Foundation of China (82103846), Key R&D and Transformation Program of Qinghai (2023-QY-204).

Indexed as

Behavioral risk factorsControlDiabetesDyslipidemiaHypertensionNon-communicable diseasesObesityPrevalenceTrends

Identifiers

PMID38456095
PMCPMC10920046
OpenAlexW4381333405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.